BONESUPPORTTM and Lund University to present at Orthopaedic Research Society (ORS) 2019 Annual Meeting

Lund, Sweden, 08.00 CET, 1 February 2019 – BONESUPPORT^TM, anemerging leader in orthobiologics for the management of bone voids, today announces two oral presentations, and three poster presentations at the upcoming Orthopaedic Research Society (ORS) 2019 Annual Meeting. The meeting takes place from February 2-5 at the Austin Convention Center in Austin, Texas and is the leading global forum for the presentation of high-quality, innovative orthopaedic research.

 

The research to be presented was carried out by Lund University in Sweden and BONESUPPORT^TM. Professor Lars Lidgren at Lund University commented: “We are pleased to complement data to be presented by BONESUPPORT on the elution of the antibiotics Gentamicin and Vancomycin from the bone graft substitute CERAMENT^® with important new findings. Our studies, performed in international collaboration, highlight the benefits of using an effective carrier platform. We find that controlled sustained local delivery of active drugs enhance bone repair and improve implant anchorage”.

 

BONESUPPORT CMO Dr. Michael Diefenbeck said: “The research on the CERAMENT platform by Lund University and their international co-workers reaffirms our confidence in the potential of our preclinical pipeline, focused on exploiting the drug eluting properties of CERAMENT based carriers, in meeting global unmet needs in both fracture repair and prevention. The potential of CERAMENT to elute different bone active drugs are clearly shown by the work from Lund University”

 

The details of the presentations are as follows:

Oral presentation:

Deepak Bushan Raina¹, Irfan Qayoom², David Larsson^1,3 Ming Hao Zheng⁴, Ashok Kumar², Hanna Isaksson^1,5, Lars Lidgren¹, Magnus Tägil¹

Guided Tissue Engineering of the Cortical and Cancellous Bone

¹Orthopedics, Lund University, Sweden

²Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, UP, India

³Medical Faculty, Umeå University, Sweden

⁴Health and Medical Sciences, University of Western Australia, Australia

⁵Biomedical Engineering, Lund University, Sweden

e-Poster with oral presentation

Deepak Bushan Raina¹, David Larsson^1,2, Erdem Aras Sezgin¹, Hanna Isaksson^1,3, Magnus Tägil¹, Lars Lidgren¹

Biomodulated Implant Increases Bone Formation and Integration

¹Orthopedics, Lund University, Sweden

²Medical Faculty, Umeå University, Sweden

³Biomedical Engineering, Lund University, Sweden

Poster presentation:

Irfan Qayoom¹, Deepak Bushan Raina², Prem Anand Murugan¹, Magnus Tägil², Matheshwaran Saravanan¹, Lars Lidgren², Ashok Kumar¹

Local drug delivery in bone tuberculosis using an injectable biphasic calcium sulphate hydroxyapatite bone cement as a carrier

¹Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, UP, India

²Department of Orthopedics, Medical Faculty, Clinical Sciences Lund, Lund University.

Christina Perdikouri, Eva Lidén, Michael Diefenbeck

Local Antibiotic Use: An in vitro and in vivo investigation of an injectable Calcium Sulfate/Calcium Phosphate Bone Graft Substitute loaded with Gentamicin or Vancomycin

BONESUPPORT AB, Lund, Sweden

Joeri Kok¹, Aurimas Širka², Lorenzo Grassi¹, Deepak Bushan Raina¹, Šarūnas Tarasevičius², Magnus Tägil¹, Lars Lidgren¹, Hanna Isaksson¹

Fracture strength of the proximal femur injected with a Calcium Sulfate/Hydroxyapatite bone substitute

¹Lund University, Lund, Sweden

²Lithuanian University of Health Sciences, Kaunas, Lithuania